Ticker Symbol: INBX
Inhibrx Inc
$43.94 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001739614
Company Profile
development of antibodies
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 11025 N. Torrey Pines Road, Suite 200
Website: https://inhibrx.com/
CEO: Mark Paul Lappe
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $17.94
Change:
$0.48
(
2.75%)
Days Range: $17.20 - $18.26
Beta: 1.48
52wk. High: $34.72
52wk. Low: $15.01
Ytd. Change -26.39%
50 Day Moving Average: $19.28
200 Day Moving Average: $21.71
Shares Outstanding: 43668153
Valuation
Market Cap: 78.3B
PE Ratio: -4.42
EPS (TTM): -4.06
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A